Behavioral Variant Frontotemporal Dementia

• CLINICAL_TRIALS trial_result · 2026-01-12
  Clinical Trial Update: Voices Of Individuals: Challenges and Experiences Of bvFTD

  This clinical trial update notes the completion of a study exploring the challenges and experiences of individuals with behavioral variant f…

• CLINICAL_TRIALS trial_result · 2025-11-21
  Clinical Trial Update: Assessment of Hyperphosphorylated Tau PET Binding in Primary Progressive Aphasia and Frontotemporal Dementia [Phase 1]

  A Phase 1 Mayo Clinic study evaluated hyperphosphorylated tau PET binding in primary progressive aphasia and behavioral variant frontotempor…

• CLINICAL_TRIALS trial_result · 2024-03-28
  Clinical Trial Update: Improving Self-Care of Behavioral Variant Frontotemporal Dementia Caregivers [NA]

  A completed clinical trial evaluated a self-care intervention for caregivers of people with behavioral variant frontotemporal dementia; resu…

• CLINICAL_TRIALS trial_result · 2023-07-06
  Clinical Trial Update: Intranasal Insulin in Frontotemporal Dementia (FTD) [Phase 2]

  Phase 2 trial of intranasal insulin for frontotemporal dementia (behavioral variant) was terminated; results posted in 2023.

• CLINICAL_TRIALS trial_result · 2020-06-02
  Clinical Trial Update: Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD) [Phase 3]

  Phase 3 open-label study of LMTM in Alzheimer's disease and behavioral variant frontotemporal dementia has been terminated; results posted i…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2018-03-14
  Clinical Trial Update: Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD) [Phase 3]

  This document announces the completion of a Phase 3 safety and efficacy study evaluating TRx0237 for behavioral variant frontotemporal demen…